Profit collapse clouds PM3 win; margin recovery unproven
The verdict, the claims that held up, the sharpest analyst exchanges, and the risks — the earnings call, decoded from the transcript.
Hold
confidence 7/10
Grade C
H1 PAT only ₹9 Cr (1.5% margin) falls sharply short of prior 16-18% EBITDA margin target. Q2 specifically shows -61% YoY profit decline and -64% QoQ decline. Implicit margin guidance downgrade is material miss.
Cautiously Optimistic
next 1–2 quarters
Optimistic
multi-year
PM3 capex delivery (59 days, record timing) is a genuine operational win with 15-17% cost reduction and 675 tpd capacity online. However, Q2 profit collapsed 61% YoY to ₹2.2 Cr on thin 0.8% margin, EBITDA margin guidance has been implicitly cut from 16-18% to 14%, and 7-11% price-hike recovery in H2 is still unproven. Risk is high: debt peaks at ₹700 Cr, input costs remain elevated, and market demand shifts to lower-GSM products that constrain premium pricing.
₹279.1 Cr
Revenue · −0.2% YoY₹2.2 Cr
Reported PAT · −61.2% YoYCompressing
Margins · vs guidance: OverstatedDid the claims hold up?
PM3 commissioned 28 Aug in record 59 days vs 65 planned
METConfirmed on call; delivered capability at 675 tpd vs prior 600 tpd
Cost reduction 15-17% achieved in raw materials and fuel
METJagdeep Hira stated both agro and wood reduction achieved; specific %age supported
H1 FY27 revenue growth 16% YoY to ₹533 Cr
METCFO stated operational income ₹533 Cr in H1; aligns with 16% growth metric
EBITDA margin guidance 16-18% by year-end FY27
MISSNow guiding ~14% for FY27 (Pushkar Jain: '14% for this year', Pavan confirmed 'Sure, sure')
Price hikes 7-11% expected in H2 FY27
MixedStated in call; only ~4% realized to date, full realization pending market acceptance
Highest monthly copier production 4,482 metric tons in Aug 2026
METCall confirms; part of PM3 ramp benefits
Earnings quality
What changed since the last call
EBITDA margin guidance cut
DowngradePrior guidance 16-18% by FY27 year-end; now implicitly 14% for full FY27 (from Pushkar Jain Q&A exchange). Material miss vs prior target.
Cost pressure narrative shift
DowngradeH1 call likely guided cost absorption via operational leverage; H2 now dependent on price hikes. Only 4% realized, 7-11% needed.
Peak debt now visible
NeutralPrior guidance 'peak debt ₹760-770 Cr'; now at ₹700 Cr and stated as peak. Debt reduction commences FY27 onward per plan.
Specialty paper portfolio expansion timeline
NewAdded target: 25-30% specialty mix within 12-15 months (now at 17-18%). Concrete timeline and product mix strategy stated.
The Q&A
Analysts pressed hard on cost details (Saania Jain), margin recovery timing (Utkarsh Nopany, Arjun Tambe), GSM mix constraints (Rishi Mody), and capital allocation (Rishi Mody on buybacks). Management held firm on price hike assumptions (7-11%) and debt reduction plan but was evasive on absolute cost figures and refused to quantify some inputs; credibility somewhat eroded.
West Asia cost impact — Saania Jain, Care PMS
Answered~2% impact on cost of sales quarterly; sulfuric acid and other chemicals most affected; impact quarterly basis
PM3 shutdown impact — Madhav Jhawar, SKP Securities
Answered~6,300 tons production loss; ~₹40 Cr EBITDA impact. Loss primarily from PM3, inventory adjustment minimal
Price hike sustainability — Utkarsh Nopany, Anand Rathi
PartialPrice hikes to be sustained at least 2 quarters in H2. Market and sector tailwinds; not temporary aberration
Capacity and Environmental clearance — Niteen Dharmawat, Aurum Edge
PartialEC application filed; approvals likely soon. Capacity optimized at ~600 tpd market-driven, not constraint-driven
Price hike numbers H2 — Samarth Singh, TPF Capital
AnsweredExpecting 7% to 11% price range in Q3-Q4. ADD already in place for kraft paperboard; writing-printing MIP under investigation, 3-6 month timeline
Cost share of starch and coal — Utkarsh Nopany, Anand Rathi
PartialStarch ~2-2.5% of paper cost; coal impact significant due to power-sector diversion; inflation expected to continue but moderation targeted by Nov-Dec
Debt and deleverage timeline — Arjun Vinay Tambe, Aurevia Crest
AnsweredPeak debt ₹700 Cr; interest/depreciation impact 3-3.5% next 2 years. Better business prospect FY27, 28 will enable deleveraging. Next financial year should reach 18-20% EBITDA
Capital expenditure and depreciation — Madhav Jhawar, SKP Securities
AnsweredCapex fully exercised; no further amounts to forecast. Depreciation ~₹80 Cr annually
GSM mix and capacity constraints — Rishi Mody, Mody Advisory
AnsweredCapability to produce 675 tpd; market trending lower so we optimize at 600 tpd. Specialty papers (70-90 gsm) and industrial mix is the strategy; product mix being adjusted daily based on market
Margin guidance FY27 and H2 — Pushkar Jain, Mili Capital
Answered14% margin guidance for FY27. Hopefully 17-18% for second half (implying FY28 H1). Current cost inflation temporary; should normalize by Nov-Dec
Government support ADD and MIP — Samarth Singh, TPF Capital
AnsweredMIP for kraft/paperboard segment accepted and notified; writing-printing MIP under investigation with 3-6 month timeline expected. Government bodies supportive; ASP (Antidumping Structural Price) duty in place
Tissue line and market consolidation — Ranveer Kataria, BRK
AnsweredNo tissue line entry currently. Consolidation happening (ITC-Century, JK acquiring smaller players); we are not consolidating, building our own specialty mix
China paper market outlook and competition — Aaryan, AV Investments
AnsweredChina is not in bad economy; facing demand issues. Chenming, Nine Dragons closed operations. Indonesia declining. Our outlook: imports stable, exports down, supply-demand balance favourable long-term
Capital allocation and buybacks — Rishi Mody, Mody Advisory
AnsweredClear focus on generating rightful cash flow to repay and service debt. No changes in equity capital structures or buyback plans. Debt repayment is priority
Guidance
FY27 annual sales value target ₹1,300 Cr+
HighH1 ₹533 Cr (pace ₹1,066 Cr annualized); ₹1,300 Cr requires strong H2. Management reaffirmed commitment but Q2 momentum (-8% QoQ) suggests execution risk
FY27 EBITDA margin ~14% (implied; prior 16-18%)
MediumCut from prior 16-18% guidance. H1 EBITDA margin ~14% (₹75Cr / ₹533Cr); Q2 shutdown depressed, but base case still weak. Q3-Q4 depend on price hikes (7-11%)
FY28 EBITDA margin target 18-20%
LowLong-term ambition; contingent on price hike realization, cost normalization, and specialty portfolio mix (25-30%). No quarterly bridging provided
H2 FY27 margin ~14% (Pushkar Jain Q: 'Our margin target will be like 14% for this year and hopefully 17, 18 for the second half?', Pavan: 'Sure, sure')
Medium17-18% margin is for FY28 H1 (next financial year), not H2 FY27. Clear downgrade from prior 16-18% FY27 guidance
Capex fully completed; no further major capex forecasted in near term
HighPM3 capex complete as of Aug 2026. Management stated capex is 'completely exercised' and 'no further amounts to forecast'. Environment projects (lime kiln, CNCGI) remaining for implementation
Risks the call surfaced
Margin recovery risk
HighOnly 4% price hike realized to date vs 7-11% needed for full offset. West Asia war, coal shortage, starch inflation ongoing. Market competitive dynamics limit pricing power.
Profit erosion / leverage
HighPeak debt at ₹700 Cr; PAT collapsed 61% YoY in Q2. If margins don't recover to 14%+ in H2-FY28, interest coverage erodes and leverage becomes stressed.
Product mix/capacity constraint
MediumPM3 capex increased capacity to 675 tpd; however, market trending toward lower GSMs (52, 54, 58) vs 64 GSM anchor. Company forced to operate at 600 tpd optimized level, limiting capex ROI.
Geopolitical/macro
MediumOcean freight volatility, coal supply diversion to power plants, global supply chain disruptions. Conflicts in West Asia reducing export volumes and increasing cost of chemical imports (sulfuric acid).
Government policy/subsidy
LowMIP for kraft segment in place; but writing-printing paper MIP still under investigation (3-6 month timeline). ADD (antidumping duties) also key for support.
Execution risk
MediumPFAS-free GSM paper launched Q3; specialty portfolio target 25-30% in 12-15 months. If customer adoption lags or pricing doesn't support target margins, specialty pivot may disappoint.
Management
Score 6/10. Mixed. Strong on operational metrics (PM3 execution, cost reduction %). Weak on transparency: refused absolute cost figures ('we won't be able to exhibit right now'), vague on price hike timing ('towards the end' initially), evasive on GSM product mix trade-offs. Some candor on challenges (West Asia, seasonal weakness) but defensive posture at times. Good on capex: PM3 delivered in 59 days vs 65-day plan (ahead of schedule). Weak on guidance: FY27 margin guidance implicitly cut from 16-18% to 14%; H1 PAT ₹9 Cr falls far short of prior-year run-rate expectations. Track record: met revenue pace but profit substantially below guidance.
1 · Nov–Dec 2026
Price realization target 7-11% in H2; market normalization post-Diwali
2 · Q3 FY27 (Oct–Dec 2026)
PM3 full-quarter operational (no shutdown), benefits realized; specialty paper launch (PFAS-free GSM oil/grease paper launched Q3)
3 · 3-6 months (likely Q4 FY27 or later)
Government decision on writing-printing paper MIP (already decided for paperboard); impacts segment economics
Risk is high: debt peaks at ₹700 Cr, input costs remain elevated, and market demand shifts to lower-GSM products that constrain premium pricing.
Informational and educational content only. Not investment advice.